AKAleksei Yu. Kneev

Aleksei Yu. Kneev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aleksei Yu. Kneev has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Imaging of active bioprosthetic valve degeneration using 68GA-FAPI-04 PET/CT: a pilot study of pathophysiological mechanisms and diagnostic value

    by A. D. Majstrenko, A. A. Ivanova, A. A. Stanzhevskij, V. E. Uspenskij, D. V. Ryzhkova, A. A. Popova, E. B. Ioffe, V. V. Zjuleva, A. Ju. Kneev, M. Gordeev

    Structural valve deterioration (SVD) remains the major limitation of bioprosthetic heart valves (BHV). Current imaging modalities (Echocardiography, CT) detect SVD at late stages of irreversible damage. This study aimed to evaluate the potential of 68Ga-FAPI-04 PET/CT, a marker of fibroblast activation, for the early visualization of active BHV remodeling and to assess its correlation with hemodynamic dysfunction. We performed a cross-sectional analysis of 30 patients with implanted aortic BHVs. All patients underwent transthoracic echocardiography and 68Ga-FAPI-04 PET/CT. Tracer uptake was quantified using the Differential Uptake Ratio (DUR). Statistical analysis included Spearman’s rank correlation, partial correlation to adjust for confounders, bootstrap analysis (5,000 resamples) for verification, and ROC analysis to determine diagnostic accuracy. DUR demonstrated a statistically significant positive correlation with peak transprosthetic pressure gradient (rs = 0.404, p = 0.027). Notably, an inverse correlation was observed between DUR and Left Ventricular Ejection Fraction (rs =–0.411, p = 0.024). Partial correlation analysis confirmed that the association between DUR and prosthetic gradients remained significant (rpartial = 0.385, p = 0.036) even after adjusting for LVEF, indicating that tracer uptake reflects intrinsic valve pathology rather than systemic heart failure. The intensity of FAP-targeted signal did not correlate with patient age or time since implantation (p >0.05). Specificity analysis showed no association between DUR and comorbidities (diabetes, renal failure) or gender. ROC analysis yielded an AUC of 0.682 (95 % CI: 0.478–0.887) for detecting severe dysfunction, with an optimal cut-off value of DUR > 2.35. The method visualizes active fibroblast-mediated remodeling in bioprosthetic valves, which correlates with hemodynamic deterioration but occurs independently of chronologic valve age and provides a specific molecular signal of SVD that is distinct from systemic factors or cardiac performance artifacts.

  • Open Access

    Quality of life assessment in patients with prostate cancer using the FACT-P questionnaire: linguistic and cultural adaptation of the Russian version

    by Aleksandr A. Zhuravlev, M. I. Shkolnik, Oleg A. Bogomolov, Aleksei Yu. Kneev, Tamara V. Sukhanova

    Aim – to perform linguistic and cultural adaptation of the international FACT-P (Functional Assessment of Cancer Therapy – Prostate) questionnaire for Russian-speaking patients with prostate cancer and to evaluate its psychometric properties. Material and methods. The adaptation process included forward and backward translation, expert review, pilot testing (n = 50), and psychometric validation. Internal consistency was assessed using Cronbach’s alpha coefficient, test/retest reliability via intraclass correlation coefficient (ICC), and construct validity by factor analysis. Results. The Russian version of FACT-P demonstrated high internal consistency across all subscales (α = 0.78–0.89), excellent test/retest reliability (ICC = 0.91), and construct validity confirmed by factor analysis. All five theoretically defined domains – physical, social, emotional, functional well-being, and prostate cancer-specific symptoms – were reliably reproduced in the sample. Most respondents noted the clarity of the wording and the relevance of the content. Conclusion. The adapted Russian-language version of the FACT-P questionnaire is a reliable, valid, and clinically significant tool for assessing the quality of life in patients with prostate cancer. It is recommended for use in clinical practice and research.


  • Detection and Quantification of Polymorphic MICA and MICB Molecules in Immunoassays: Initial Insights

    by A. Yu. Stolbovaya, A. A. Pinevich, I. V. Gryazeva, I. Yu. Krutetskaya, G. M. Zharinov, M. A. Morozova, A. Yu. Kneev, L. A. Terekhina, S. A. Ishchuk, O. A. Shashkova, et al.

    The MICA and MICB molecules, expressed on the cell membrane in response to cellular stress or cancer transformation, pose significant challenges for immunoassays. They exhibit high sequence and structural similarity, alongside considerable allelic polymorphism, with 291 and 53 known protein sequences, respectively. Some researchers treat MICA and MICB as a unified target because of their structural and functional similarities, while others distinguish between them. However, which approach is superior and under what circumstances remains unknown. Moreover, information about assays' reactivity with MICA and MICB allelic variants is often missing. In this study, we developed 10 monoclonal antibodies (mAbs) and two sandwich ELISAs for the detection and quantification of these molecules. We assembled a panel of recombinant proteins representing the diversity of MICA and MICB in the European population and profiled the reactivities of the mAbs and ELISAs. The performance of these sandwich ELISAs was evaluated using samples from prostate cancer patients and pregnant women experiencing premature rupture of membranes. Our study assessed the impact of MICA and MICB polymorphism on their detection and quantification by immunological methods, providing evidence to support differential or non‐differential approaches for their detection.


  • Open Access

    Algorithm for Constructing the Hazard Function of the Extended Cox Model and its Application to the Prostate Cancer Patient Database

    by I. I. Mikulik, G. M. Zharinov, A. Yu. Kneev

    Introduction. In medicine and related industries, bioinspired approaches are used for the survival analysis, among which the Cox regression model holds a specific place. The practice of its application is described in the theoretical and applied literature. However, a significant drawback of this method requires careful study. The fact is that the features correlate with the hazard function linearly, and the model does not use more complex dependences. This causes some difficulties in studying survival analysis. The presented work is aimed at solving this problem. The object of study is the extended Cox model, in which the hazard function includes a nonlinear combination of features.Materials and Methods. A database of prostate cancer patients was used, since this is a common diagnosis in global oncology. A class of extended Cox models with an additive/multiplicative hazard function was defined. To solve the problem using the optimization method, a fitness function was constructed that evaluated the results of prognosis, the number of features, and the degree of overtraining of the model — the complexity and load of the compiled hazard function. An algorithm of pollinating ants has been developed to optimize the fitness function. It simulates the reproduction of flowering plants using pollinating insects and consists of three parts: an ant colony algorithm, a genetic algorithm, and an ant pollinator algorithm. The quality of training of the Cox model was assessed by C-index.Results. A metaheuristic algorithm for ant pollinator optimizing was proposed, providing for the construction of hazard functions of the extended Cox model. The set of parameters for training the standard Cox model was the entire set of features used: TNM, prostate-specific antigen doubling time (PSADT), Gleason score, serum PSA concentration at diagnosis, patient age and education, Rh factor. C-index value of the trained model was 0.853691. The extended Cox model with the found additive/multiplicative hazard function had a higher C-index value — 0.856241 with a smaller number of features used (TNM, PSADT, and Gleason score). In terms of quality, this approach is not inferior to or superior to the classical Cox model. Reducing the number of features involved should improve the efficiency of medical decisions and speed up the start of treatment.Discussion and Conclusion. The presented algorithm for constructing survival analysis models increased the accuracy of predicting the occurrence of a terminal event, and reduced the number of features used for this purpose. The difference in accuracy for the studied data set seemed insignificant — C-index increased from 0.853691 to 0.856241 (by 0.3%). At this, the number of features taken into account was reduced from 7 to 3 (by 57.1%). Consequently, the proposed method effectively solves the problem of feature selection, and can be applied to improve the quality of prognostication.


  • Open Access

    Migration of Hem-o-Lok clips into the bladder after radical prostatectomy – own experience

    by O. A. Bogomolov, T. V. Sukhanova, M. I. Shkolnik, A. Yu. Kneev, A. L. Dolbov, М. V. Artemov, Суханова Тамара Владимировна

    Non-absorbable polymer Hem-o-Lok clips are widely used during nerve-sparing radical prostatectomy for clipping of the neurovascular bundle, as well as for rapid knotless fixation of sutures during the formation of urethrovesical anastomosis. At the same time, cases of migration of Hem-o-Lok clips into the bladder at various times after RP have been described. Our retrospective analysis of 1321 patients, who underwent laparoscopic radical prostatectomy at A.M. Granov Russian Scientific Center of Radiology and Surgical Technologies from 2014 to 2023, revealed 3 cases of Hem-o-Lok clip intravesical migration. Also, to search for similar cases of this rare complication a literature review was conducted. The frequency of postoperative intra-bladder clip migration in our study was 0.23 % (3/1321). One case of spontaneous clip passage was observed 3 months later the radical prostatectomy. In two other cases, long-term symptoms of dysuria (in 7 months and 4 years, respectively) revealed clip incrustation, which led to the removal of the clips through endoscopic intervention and laser cystolithotripsy. Despite the low incidence of this complication, the use of Hem-o-Lok clips during laparoscopic radical prostatectomy, should be minimized reasonably, particularly during the urethro-vesical anastomosis formation. If lower urinary tract symptoms and/or hematuria occur at any point in the postoperative period, it’s advisable to conduct an instrumental examination of the bladder to rule out potential clip migration and possible incrustation.


  • Open Access

    Prognostic value of immunological components of tumor microenvironment of oncourological tumors

    by Oleg E. Molchanov, Dmitrii N. Maistrenko, Dmitrii A. Granov, Mikhail I. Shkolnik, Igor Yu. Lisitsyn, Andrei D. Belov, Aleksei Yu. Kneev, Майстренко Дмитрий Николаевич

    BACKGROUND: In the last decade, the tumor microenvironment has been considered as one of the key factors determining the prognosis and nature of the necessary therapeutic interventions. Currently, there is only one validated and approved predictive model that includes microenvironment components. Several classifications of the tumor microenvironment based on the nature of the predominant cellular subpopulations have been proposed. AIM: The aim of the study was to assess the prognostic significance of the immunological components of blood and the microenvironment, as well as to create prognostic models for oncourological tumors. MATERIALS AND METHODS: The study used clinical data from 115 patients with kidney, bladder and prostate cancer. Immunological parameters in the tumor and blood microenvironment were evaluated in all patients. The end point of observation was the median time to progression. The influence of various parameters on long-term treatment outcomes was evaluated using the log rank and the Gehan–Wilcoxon criteria. A model of proportional hazard was used to identify the combined effect of several parameters on lifetime indicators. RESULTS: The developed prognostic models for all studied groups include spontaneous production of three cytokines: IL-6, IL-8 and IL-10. The prognostic models for renal cell carcinoma and prostate cancer also included immunosuppressive components: MDSC and Treg. The median time to progression in patients with invasive urothelial cancer is influenced by components that contribute to tumor destruction: TNK cells and IFN-γ. In all the studied groups of patients (renal cell carcinoma, muscle-invasive urothelial cancer, prostate cancer), the median time to progression significantly differs in subgroups with different numbers of immunological risk factors for tumor microenvironment. CONCLUSIONS: The developed prognostic models are based on modern achievements of oncoimmunology and after conducting multicenter validation studies, they can be recommended for clinical use.


  • Open Access

    Prostate-specific antigen density as a predictor of recurrence-free survival following combined hormonal-radiation therapy of localized prostate cancer

    by A. Yu. Kneev, M. I. Shkolnik, O. A. Bogomolov, N. D. Verdiev, G. M. Zharinov

    Background. Prostate cancer is amongst one of the most prevalent cancers in men worldwide. Combined hormonal-radiation therapy has become a standard of care for localized prostate cancer definitive treatment. As many as 30 % of men are at risk for disease progression within 10 years following radical treatment.Aim. To assess the significance of prostate-specific antigen (PSA) density as a predictor of recurrence-free survival following combined hormonal-radiation therapy in patients with localized prostate cancer.Materials and methods. We conducted a retrospective study of 272 patients with clinically localized prostate cancer treatment results who received combined hormonal-radiation therapy between January 1996 and December 2016.Results. On the basis of our study, we confirmed high prognostic value of PSA density among patients with localized prostate cancer who received combined hormonal-radiation treatment. We utilized ROC-analysis in order to determine the threshold value of the PSA density index – 0.376 ng/ml/cm3, exceeding of which was associated with statistically significant reduction in the recurrence-free survival rate. The area under the curve was 0.711 (95 % confidence interval 0.653–0.764; p 0.0001). The risk of recurrence increased with rising of PSA density.Conclusion. PSA density has proven to be a reliable tool for assessing the risk of prostate cancer recurrence among patients with localized prostate cancer who have undergone combined hormonal-radiation therapy.

  • Open Access

    Prostate specif c antigen density as a prognostic factor in patients with prostate cancer treated with combined hormonal radiation therapy

    by A. Y. Kneev, M. I. Shkol’nIk, O. A. Bogomolov, G. M. Zharinov

    Purpose. To evaluate prostate specifc antigen density (PSAD) as a predictor of overall (OS) and cancerspecifc survival (CSS) in patients with prostate cancer (PC) who have undergone combined hormonal-radiation therapy.Material and Methods. In order to assess the prognostic signifcance of PSAD we retrospectively analyzed outcomes of 714 PCa patients who received combined hormonal-radiation therapy at the A.M. Granov Russian Scientifc Center of Radiology and Surgical Technologies, Ministry of Healthcare of Russia, between January 1996 and December 2016. Since the prognosis and management differ according to the extent of tumor involvement, patients were categorized into localized (n=272), locally advanced (n=231) and metastatic (n=211) PC groups. We equentially applied ROC-analysis, Kaplan-Meier product limit estimator and Cox proportional hazards model to assess the prognostic relevance and establish threshold values of PSAD that had a signifcant impact on survival rates.Results. In the localized PC group, PSAD threshold values of 0.34 ng/mL/cc and 0.36 ng/mL/cc were associated with a decrease in OS and CSS, respectively. Patients with “low” PSAD had signifcantly better OS and CSS survival rates in both uni- and multivariate analyses. In locally advanced PC group, PSAD threshold values were 0.28 ng/mL/cc and 0.63 ng/mL/cc for OS and CSS, respectively. However, exceeding the specifed values, in the locally advanced PC group, was not accompanied by a statistically signifcant decrease in survival rates. Finally, in the metastatic PC group, established PSAD threshold values were 2.25 ng/mL/cc and 2.30 ng/mL/ccfor OS and CSS, respectively. According to the results of univariate analysis, patients with “low” PSA tend to demonstrate statistically signifcant better OS and CSS rates. The results of multivariate analysis, however, failed to prove PSAD as an independent prognostic factor within the metastatic PC cohort. Conclusion. PSA density is a reliable tool for assessing survival rates in patients with localized PC who have undergone combined hormonal-radiation therapy.


  • Endoscopic treatment of urethrovesical anastomosis leakage following radical prostatectomy

    by O.A. Bogomolov, D.A. Timofeev, M.I. Shkolnik, A.YU. Kneev, Z.K. Emirgaev, S.A. Sidorova

    ЦЕЛЬ ИССЛЕДОВАНИЯ Демонстрация эндоскопического способа устранения несостоятельности уретровезикального анастомоза после лапароскопической радикальной простатэктомии и анализ его результатов. МАТЕРИАЛ И МЕТОДЫ Проанализированы результаты эндоскопического способа устранения несостоятельности уретровезикального анастомоза у 15 пациентов, перенесших лапароскопическую радикальную простатэктомию по поводу рака простаты в ФГБУ «РНЦРХТ им. акад. А.М. Гранова». В основу способа легла методика наружновнутреннего стентирования обоих мочеточников. РЕЗУЛЬТАТЫ У 14 пациентов отмечено полное заживление уретровезикального анастомоза. У 1 пациента выявлено формирование стриктуры уретры, потребовавшей бужирования и в дальнейшем ее лазерного рассечения. Средняя длительность заживления уретровезикального анастомоза составила 4±1 день. ЗАКЛЮЧЕНИЕ Эндоскопическое стентирование мочеточников у больных с несостоятельностью уретровезикального анастомоза после радикальной простатэктомии является альтернативой консервативным или другим инвазивным способам ее коррекции.

  • Prostate-specific antigen density as a prognostic marker in patients with localized prostate cancer

    by Alexey Yu. Kneev, Michail I. Shkolnik, Oleg A. Bogomolov, Julia G. Vershinskaya, Gennady M. Zharinov, Вершинская Юлия Геогиевна

    BACKGROUND: The most important task in the field of improving the results of treatment of patients with prostate cancer (PCa) is their correct stratification by risk groups. Modern stratification systems do not fully provide an adequate risk assessment for all patients with prostate cancer. Further development of algorithms for predicting the clinical course of prostate cancer for a particular patient can positively affect the course and outcome of the disease. AIM: Determination of the clinical and prognostic value of the density of prostate-specific antigen (PSAD) in patients with localized prostate cancer who underwent combined external beam radiation with androgen deprivation therapy. MATERIALS AND METHODS: The effect of the PSAD parameter on the tumor-specific survival rates, as well as the clinical and morphological parameters of the tumor process, was assessed in 272 patients with localized prostate cancer who underwent combined external beam radiation with androgen deprivation therapy from January 1996 to July 2007. RESULTS: The high clinical significance of the PSAD indicator has been demonstrated. An increase in PSAD correlated with an increase in serum PSA concentration, a decrease in PSA doubling time, and a decrease in tumor differentiation. The prognostic value of PSAD was confirmed in patients with localized prostate cancer who received combined hormone-radiation therapy. Using ROC-analysis, the threshold value of the PSAD index was determined 0.36 ng / ml / cm3, the excess of which was associated with a statistically significant decrease in the level of tumor-specific survival. The area under the curve was 0.703 (95% CI 0.2360.434; p 0.001). The risk of tumor-specific mortality and recurrence increased as the PSAD value increased. CONCLUSION: The PSAD parameter is a reliable biomarker of prostate cancer with high rates of clinical and prognostic significance, the use of which is not associated with the introduction of costly and cumbersome methods of laboratory and instrumental diagnostics.